In spite of this, Atranorin and Kurarinon significantly prevented T2D‐increased serum LDH and CK‐MB levels by inhibiting the protein expression of Decr1 (Figure 8c). This evidence concerns the gene DECR1 and type 2 diabetes mellitus.